Burning Rock Biotech (BNR) Enterprise Value (2019 - 2026)

Burning Rock Biotech's Enterprise Value history runs 8 years deep, the most recent figure standing at -$70.1 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 2.95% year-over-year to -$70.1 million; the TTM figure through Mar 2026 stood at -$70.1 million (up 2.95% YoY), while the FY2025 annual figure was -$67.8 million, up 5.18% from the prior year.
• Enterprise Value for Q1 2026 stood at -$70.1 million, down from -$67.8 million in the prior quarter.
• The five-year high for Enterprise Value was -$65.6 million in Q3 2025, with the low at -$228.4 million in Q1 2022.
• The 5-year median for Enterprise Value is -$85.4 million (2023), against an average of -$105.9 million.
• The sharpest annual moves came in 2022 and 2026: Enterprise Value surged 47.94% in 2022, then increased 2.95% in 2026.
• Burning Rock Biotech's Enterprise Value stood at -$130.1 million in 2022, then soared by 34.32% to -$85.4 million in 2023, then climbed by 14.92% to -$72.7 million in 2024, then increased by 6.69% to -$67.8 million in 2025, then declined by 3.4% to -$70.1 million in 2026.
• Business Quant data shows BNR's Enterprise Value at -$70.1 million in Q1 2026, -$67.8 million in Q4 2025, and -$65.6 million in Q3 2025.